News & Views

News & Views

  • The ALRT Diabetes Management System in Action

    New video presentation shows how health care providers use the features of ALRT’s Diabetes Management System to support patients with Type 2 Diabetes. (October 23, 2017 -- RICHMOND, VA) Following the recent FDA clearance of the Company’s Insulin Dose Adjustment feature and release of its patent pending Predictive A1C innovation, ALR Technologies Inc. (“ALRT” or the “Company”) has released a new video presentation to show how health care providers are supported by the ALRT Diabetes Management …

    Read More...
  • The ALRT Diabetes Management System

    Details of the patent pending diabetes management system featuring Predictive A1C and Insulin Dose Adjustment (October 16, 2017 -- RICHMOND, VA) Following the recent FDA clearance of the Company’s Insulin Dose Adjustment feature, ALR Technologies Inc. (“ALRT” or the “Company”) is releasing details of its patent pending Predictive A1C innovation added to the ALRT Diabetes Management System. Details of the innovative features are presented in five videos. First, “How Does The ALRT Diabetes …

    Read More...
  • ALRT Adding International Reference Dosing to Insulin Dose Adjustment (IDA) Feature for International Market Expansion

    Product development underway to add reference doses based on International Diabetes Federation, Australia, Canada, New Zealand and UK Guidelines (September 25, 2017 -- RICHMOND, VA) On September 18, 2017, the United States Food and Drug Administration (FDA) granted clearance to ALR Technologies Inc. (OTCQB: ALRT) for an innovative insulin dose adjustment (IDA) feature of the ALRT diabetes management system. The ALRT system with IDA uses the American Association of Clinical Endocrinologists ( …

    Read More...
  • FDA Grants ALRT Clearance for Insulin Dose Adjustment (IDA) Feature

    IDA is designed to ensure that patients get an effective and timely insulin dose(s) based on accurate data about their specific needs (September 19, 2017 -- RICHMOND, VA) The United States Food and Drug Administration (FDA) has granted clearance to ALR Technologies Inc. (OTCQB: ALRT) for an innovative insulin dose adjustment (IDA) feature of the ALRT diabetes management system. The ALRT system with IDA uses the American Association of Clinical Endocrinologists (AACE) and American Diabetes …

    Read More...
  • ALRT Introduces Value Pricing for Diabetes Management

    Risk Sharing Plan Means Users Will Pay for Service Only When Specific Health Measures Are Met (RICHMOND, VA, December 21, 2015) Medical practices, health insurers, self-insured employers, and other potential users of the ALRT diabetes management system can now choose a pricing plan linked to declines in a patient’s A1C level. The plan is designed to eliminate performance risk and to provide rewards for achieving measurable health goals. “Payers are frustrated with expensive diabetes …

    Read More...
  • ALRT System Significantly Lowers A1C Levels in Type 2 Diabetes Patients in Real World Pilot Program

    Program Yields Significant Improvement in Glycemic Control for Clinics’ Most Challenging Patients (RICHMOND, VA, November 17, 2015) A 10-month pilot of the ALRT remote monitoring system for diabetes by the Kansas City Metropolitan Physician Association (KCMPA) has found significant improvement in glycemic control for those patients who used the system compared to those who dropped out of the pilot. Patients participating in the pilot program of the ALRT system experienced an average A1C …

    Read More...
  • ALR Technologies Seeks FDA Approval For Insulin Dose Adjustment Feature for Better Diabetes Management

    ALRT’s Algorithm Helps Physicians Optimize Treatment And Avoid Complications (February 17, 2015 -- RICHMOND, VA) ALR Technologies Inc. (OTCQB: ALRT), a leading remote chronic care management and medical device company, is pleased to announce the submission of a 510(k) application to the U.S. Food and Drug Administration (FDA) for an innovative new addition to the Health-e-Connect system that will help busy physicians avoid common insulin dosing errors and remotely manage large populations of …

    Read More...
  • Tech firm breaks into health market

    Richmond Bizsense – April 29, 2015 A local technology company has landed its first paid client since making a strategic shift toward disease monitoring systems two years ago. ALR Technologies, which offers a platform to remotely monitor diabetes patients, has signed a contract with Clay Platte Family Medicine Clinic. The deal will give ALRT and its Internet-based Health-e-Connect system access to the Kansas City, Missouri, primary care clinic’s 3,400 diabetes patients. Data uploaded …

    Read More...
  • ALR Technologies Signs First Revenue-Generating Contract

    Health-e-Connect System Deployed to Improve Diabetes Outcomes at Leading Kansas City Medical Group (April 20, 2015 -- RICHMOND, VA) ALR Technologies Inc. (OTCQB: ALRT), a leading remote chronic care management and medical device company, is pleased to announce that Clay-Platte Family Medicine Clinic, one of the largest primary care clinics in the Northland of Kansas City, has signed a contract with ALRT to improve diabetes health outcomes using the Health-e-Connect remote chronic care …

    Read More...
  • Nipro to Partner with ALR Technologies on Chilean Clinical Trial

    Outcomes Study with Hospital Clinico Metropolitano La Florida will test the efficacy of remote monitoring and remote insulin adjustments; Nipro to provide their latest FDA-cleared glucose meters, diagnostic supplies and enrollment support RICHMOND, Va., Jan. 20, 2015 - ALR Technologies Inc. (ALRT) announced that Nipro Diagnostics, Inc. and Nipro Medical Corporation have agreed to participate in a clinical outcomes study to be conducted by ALRT and Hospital Clinico Metropolitano La Florida, one …

    Read More...

News: Yes